These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 20695297)
21. Alpers syndrome: progressive neuronal degeneration of children with liver disease. Gordon N Dev Med Child Neurol; 2006 Dec; 48(12):1001-3. PubMed ID: 17109792 [TBL] [Abstract][Full Text] [Related]
22. [Variation in manifestations of heteroplasmic mtDNA mutation 8993 T>G in two families]. Tesarová M; Hansíková H; Hlavatá A; Klement P; Houst'ková H; Houstĕk J; Zeman J Cas Lek Cesk; 2002 Aug; 141(17):551-4. PubMed ID: 12404959 [TBL] [Abstract][Full Text] [Related]
23. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats. Elwakkad AS; El Elshamy KA; Sibaii H Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911 [TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine. Waberzinek G; Marková J; Mastík J Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725 [TBL] [Abstract][Full Text] [Related]
25. [Early mitochondrial encephalomyopathy due to complex IV deficiency consistent with Alpers-Huttenlocher syndrome: report of two cases]. Castro-Gago M; González-Conde V; Fernández-Seara MJ; Rodrigo-Sáez E; Fernández-Cebrián S; Alonso-Martín A; Campos Y; Arenas J; Eirís-Puñal J Rev Neurol; 1999 Nov 16-30; 29(10):912-7. PubMed ID: 10637838 [TBL] [Abstract][Full Text] [Related]
26. [Hemorrhagic shock and fulminant hepatic failure associated with valproate]. Fernandez-Fernandez FJ; Garcia-Rego J; Garcia-Jimenez A; Sesma P An Med Interna; 1995 Dec; 12(12):606-8. PubMed ID: 8679806 [TBL] [Abstract][Full Text] [Related]
27. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial. Mitsikostas DD; Polychronidis I Funct Neurol; 1997; 12(5):267-76. PubMed ID: 9439944 [TBL] [Abstract][Full Text] [Related]
28. Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1). McFarland R; Hudson G; Taylor RW; Green SH; Hodges S; McKiernan PJ; Chinnery PF; Ramesh V Arch Dis Child; 2008 Feb; 93(2):151-3. PubMed ID: 18208989 [TBL] [Abstract][Full Text] [Related]
30. Acute leukemia associated with valproic acid treatment: a novel mechanism for leukemogenesis? Coyle TE; Bair AK; Stein C; Vajpayee N; Mehdi S; Wright J Am J Hematol; 2005 Apr; 78(4):256-60. PubMed ID: 15795916 [TBL] [Abstract][Full Text] [Related]
31. A suspected case of late-onset sodium-valproate-induced hepatic failure. van Egmond H; Degomme P; de Simpel H; Dierick AM; Roels H Neuropediatrics; 1987 May; 18(2):96-8. PubMed ID: 3110642 [TBL] [Abstract][Full Text] [Related]
32. A case of pancytopenia. Keown P; McAllister-Williams H; Young A J Psychopharmacol; 2006 Sep; 20(5):690-2. PubMed ID: 16714327 [TBL] [Abstract][Full Text] [Related]
33. Valproate-associated dysmyelopoiesis in elderly patients. So CC; Wong KF Am J Clin Pathol; 2002 Aug; 118(2):225-8. PubMed ID: 12162682 [TBL] [Abstract][Full Text] [Related]
34. [Valproate-associated hyperammonemic encephalopathy. Report of one case]. Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656 [TBL] [Abstract][Full Text] [Related]